A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine

AIDS. 2006 Mar 21;20(5):787-9. doi: 10.1097/01.aids.0000216387.60481.0e.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active
  • Drug Resistance, Viral / genetics
  • HIV Infections / drug therapy*
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / enzymology*
  • Humans
  • Male
  • Mutation*
  • Reverse Transcriptase Inhibitors / therapeutic use*

Substances

  • Reverse Transcriptase Inhibitors
  • HIV Reverse Transcriptase